Market Currents
Shares of Theravence (THRX -33.4%) crater after the firm's Phase III results for Relovair...
-
Monday, January 9, 2012, 9:56 AM ETShares of Theravence (THRX -33.4%) crater after the firm's Phase III results for Relovair (previous) includes the disclosure of pneumonia-related deaths in patients.
Other date
Latest Articles
